NPPA Fixes Retail Price Of 75 Drug Formulations

New Delhi : India’s drug price regulator, the National Pharmaceutical Pricing Authority (NPPA), has fixed retail price of 75 formulations, which include medications to treat diabetes and high blood pressure.

The NPPA is mandated to fix or revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country. It also monitors the prices of decontrolled drugs in order to keep them at reasonable levels.

Price revisions by the regulator was decided upon following its 109 th meeting held on February 21.

As per the notification, the NPPA has fixed the price of one tablet of Dapagliflozin Sitagliptin and Metformin Hydrochloride at ₹27.75. These medicines find usage in diabetes treatment.

Similarly, the regulator has fixed the price of one tablet of blood pressure lowering medication Telmisartan and Bisoprolol Fumarate tablets at ₹10.92.

Ceiling price of 80 scheduled formulations (NLEM 2022) including the one to treat epilepsy and neutropenia has also been revised, it said.

The ceiling price of one tablet (200mg) of Sodium Valproate has been fixed at ₹3.20. Similarly, the ceiling price of Filgrastim injection (one vial) has been fixed at ₹1,034.51.

The price of one tablet of Hydrocortisone (20 mg), a steroid, has been fixed at ₹13.28.

  • Related Posts

    • Pharma
    • April 28, 2025
    • 97 views
    Gujrat leads pharma sector with record 183 new plants

    Ahmedabad:  Gujarat has further cemented its position as India’s pharmaceutical powerhouse with the state’s Food and Drug Control Administration (FDCA) approving 183 new allopathic drug manufacturing facilities in FY 2024-25,…

    • Pharma
    • April 28, 2025
    • 108 views
    Doctor not liable for prescribing costly drug: HC

    Cuttack:  Orissa high court has ruled that a doctor should not be held criminally liable for prescribing a particular drug of any pharmaceutical company for treatment of a disease like…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gujrat leads pharma sector with record 183 new plants

    Gujrat leads pharma sector with record 183 new plants

    Doctor not liable for prescribing costly drug: HC

    Doctor not liable for prescribing costly drug: HC

    878 Tramadol capsules being smuggled in Scorpio seized, three arrested

    878 Tramadol capsules being smuggled in Scorpio seized, three arrested

    Doctor not criminally liable for prescribing costly drug: Orissa High Court

    Doctor not criminally liable for prescribing costly drug: Orissa High Court

    Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

    Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

    Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

    Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion